Research & Development



青陽秀才陳蔚,字豹章,能文,愛客,受業隨園。《江行雜詠》雲︰“日沉遠樹青,煙起遙山失。何處艤孤舟?一燈古渡出。昨發螃蟹磯,今泊針魚觜。秋風一夜生,吟冷半江水。”隨其兄芳郁庭遠行雲︰“江梅開遍雨霏霏,同駐郵亭整客衣。今日反嗟人似雁,一行齊向異鄉飛。”郁庭有《草堂雜詠》雲︰“處士應門惟使鶴,高人去榻更無賓。小橋時有雲遮斷,不使游人過水西。”兄弟俱耽吟詠,人以雙丁、二陸比之。 八夜夜视频网 明季以來,宋學太盛。于是近今之士,競尊漢儒之學,排擊宋儒,幾乎南北皆是矣。豪健者尤爭先焉。不知宋儒鑿空,漢儒尤鑿空也。康成臆說,如用麒麟皮作鼓郊天之類,不一而足。其時孔北海、虞仲翔早駁正之。孟子守先王之道,以待後之學者,尚且周室班爵祿之制,其詳不可得而聞。又曰︰“盡信書,不如無書。”況後人哉?善乎楊用修之詩曰︰“三代後無真理學,‘六經’中有偽文章。”夜夜擼日日日射 日日夜夜鲁

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo